Obesity and dementia: Adipokines interact with the brain

European Neuropsychopharmacology

Volumn 24, Issue 12, 2014, Pages 1982-1999

  Arnoldussen, Ilse A C ^a   Kiliaan, Amanda J ^a   Gustafson, Deborah R ^b,c,d  

^a RADBOUD UNIVERSITY   (Netherlands)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c UMS 011   (France)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adipokines; Alzheimer; Brain; Dementia; Leptin; Obesity

Indexed keywords

ADIPONECTIN; ANGIOTENSINOGEN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE;

ADIPOSE TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CALORIC INTAKE; DEMENTIA; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; NONHUMAN; OBESITY; PROTEIN FUNCTION; PROTEIN INTERACTION; ANIMAL; BIOLOGICAL MODEL; BRAIN; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY;

ADIPOKINES; ADIPONECTIN; ANGIOTENSINOGEN; ANIMALS; BRAIN; DEMENTIA; HUMANS; INTERLEUKIN-6; LEPTIN; MODELS, BIOLOGICAL; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902454114     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.03.002     Document Type: Article

References (227)

1. Adeghate E. Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr. Med. Chem. 2008, 15:1851-1862.
2. Ahima R.S. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 2006, 14(Suppl. 5):242S-249S.
3. Ahima R.S., Bjorbaek C., Osei S., Flier J.S. Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology 1999, 140:2755-2762.
4. Ahn M.Y., Zhang Z.G., Tsang W., Chopp M. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain. Res. 1999, 837:169-176.
5. Allen A.M., Dampney R.A., Mendelsohn F.A. Angiotensin receptor binding and pressor effects in cat subretrofacial nucleus. Am. J. Physiol. 1988, 255:H1011-H1017.
6. Andreatta S.H., Averill D.B., Santos R.A., Ferrario C.M. The ventrolateral medulla. A new site of action of the renin-angiotensin system. Hypertension 1988, 11:I163-I166.
7. Arch J.R., Stock M.J., Trayhurn P. Leptin resistance in obese humans: does it exist and what does it mean?. Int. J. Obes. Relat. Metab. Disord. 1998, 22:1159-1163.
8. Averill D.B., Diz D.I., Barnes K.L., Ferrario C.M. Pressor responses of angiotensin II microinjected into the dorsomedial medulla of the dog. Brain Res. 1987, 414:294-300.
9. Bader M., Ganten D. It's renin in the brain: transgenic animals elucidate the brain renin angiotensin system. Circ. Res. 2002, 90:8-10.
10. Balschun D., Wetzel W., Del Rey A., Pitossi F., Schneider H., Zuschratter W., Besedovsky H.O. Interleukin-6: a cytokine to forget. FASEB J. 2004, 18:1788-1790.
11. Banks W.A. Denial versus dualism: the blood-brain barrier as an interface of the gut-brain axis. Endocrinology 2006, 147:2609-2610.
12. Banks W.A., Clever C.M., Farrell C.L. Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E1158-E1165.
13. Banks W.A., DiPalma C.R., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20:1341-1345.
14. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 1994, 179:53-56.
15. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
16. Banks W.A., Lebel C.R. Strategies for the delivery of leptin to the CNS. J. Drug Target. 2002, 10:297-308.
17. 2+ accumulation. Proc. Natl. Acad. Sci. USA 1995, 92:9328-9332.
18. Baumann H., Morella K.K., White D.W., Dembski M., Bailon P.S., Kim H., Lai C.F., Tartaglia L.A. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 1996, 93:8374-8378.
19. Baune B.T., Ponath G., Rothermundt M., Riess O., Funke H., Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 2008, 33:68-76.
20. Baune B.T., Wiede F., Braun A., Golledge J., Arolt V., Koerner H. Cognitive dysfunction in mice deficient for TNF- and its receptors. Am. J. Med. Genet. Part B, Neuropsychiatr. Gen.: Off. Publ. Int. Soc. Psychiatr. Genet. 2008, 147B:1056-1064.
21. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
22. Beltowski J. Adiponectin and resistin-new hormones of white adipose tissue. Medical Sci. Monit.: Int. Med. J. Exp. Clin. Res. 2003, 9:RA55-RA61.
23. Besser L.M., Gill D.P., Monsell S.E., Brenowitz W., Moranus D., Kukull W.A., Gustafson D.R. Body Mass Index, weight change, and clinical progression in mild cognitive impairment and Alzheimer's disease. Alzheimer Dis. Assoc. Disord 2014, 28:36-43.
24. Beste C., Baune B.T., Falkenstein M., Konrad C. Variations in the TNF-alpha gene (TNF-alpha-308G→A) affect attention and action selection mechanisms in a dissociated fashion. J. Neurophysiol. 2010, 104:2523-2531.
25. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. cell 1998, 1:619-625.
26. Bjorbaek C., Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res. 2004, 59:305-331.
27. Bjorbaek C., Uotani S., da Silva B., Flier J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 1997, 272:32686-32695.
28. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
29. Bouret S.G. Neurodevelopmental actions of leptin. Brain Res. 2010, 1350:2-9.
30. Bray G.A., Popkin B.M. Dietary fat intake does affect obesity!. Am. J. Clin. Nutr. 1998, 68:1157-1173.
31. Brooks S.J., Benedict C., Burgos J., Kempton M.J., Kullberg J., Nordenskjold R., Kilander L., Nylander R., Larsson E.M., Johansson L., Ahlstrom H., Lind L., Schioth H.B. Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study. Int. J. Obes 2012.
32. Brown R., Imran S.A., Belsham D.D., Ur E., Wilkinson M. Adipokine gene expression in a novel hypothalamic neuronal cell line: resistin-dependent regulation of fasting-induced adipose factor and SOCS-3. Neuroendocrinology 2007, 85:232-241.
33. Brown R., Thompson H.J., Imran S.A., Ur E., Wilkinson M. Traumatic brain injury induces adipokine gene expression in rat brain. Neurosci. Lett. 2008, 432:73-78.
34. Burguera B., Couce M.E., Curran G.L., Jensen M.D., Lloyd R.V., Cleary M.P., Poduslo J.F. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 2000, 49:1219-1223.
35. Burguera B., Couce M.E., Long J., Lamsam J., Laakso K., Jensen M.D., Parisi J.E., Lloyd R.V. The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain. Neuroendocrinology 2000, 71:187-195.
36. Businaro R., Ippoliti F., Ricci S., Canitano N., Fuso A. Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectives. Curr. Gerontol. Geriatr. Res. 2012, 2012:986823.
37. Butler M.P., O'Connor J.J., Moynagh P.N. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 2004, 124:319-326.
38. Cacci E., Claasen J.H., Kokaia Z. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 2005, 80:789-797.
39. Caro J.F., Kolaczynski J.W., Nyce M.R., Ohannesian J.P., Opentanova I., Goldman W.H., Lynn R.B., Zhang P.L., Sinha M.K., Considine R.V. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996, 348:159-161.
40. Cazettes F., Cohen J.I., Yau P.L., Talbot H., Convit A. Obesity-mediated inflammation may damage the brain circuit that regulates food intake. Brain Res. 2011, 1373:101-109.
41. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153.
42. Chung I.Y., Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 1990, 144:2999-3007.
43. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
44. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996, 334:292-295.
45. Crowley S.D., Coffman T.M. Recent advances involving the renin-angiotensin system. Exp. Cell Res. 2012, 318:1049-1056.
46. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 1996, 203:17-20.
47. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
48. Delgado T.C., Violante I.R., Nieto-Charques L., Cerdan S. Neuroglial metabolic compartmentation underlying leptin deficiency in the obese ob/ob mice as detected by magnetic resonance imaging and spectroscopy methods. J. Cereb. Blood Flow Metab. 2011, 31:2257-2266.
49. Di Simone N., Di Nicuolo F., Sanguinetti M., Castellani R., D'Asta M., Caforio L., Caruso A. Resistin regulates human choriocarcinoma cell invasive behavior and endothelial cell angiogenic processes. J. Endocrinol. 2006, 189:691-699.
50. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003, 148:293-300.
51. Doherty G.H. Obesity and the ageing brain: could leptin play a role in neurodegeneration?. Curr. Gerontol. Geriatr. Res. 2011, 2011:708154.
52. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 2000, 105:1827-1832.
53. Fabry Z., Fitzsimmons K.M., Herlein J.A., Moninger T.O., Dobbs M.B., Hart M.N. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 1993, 47:23-34.
54. Farr S.A., Banks W.A., Morley J.E. Effects of leptin on memory processing. Peptides 2006, 27:1420-1425.
55. Fitzpatrick A.L., Kuller L.H., Lopez O.L., Diehr P., O'Meara E.S., Longstreth W.T., Luchsinger J.A. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch. Neurol. 2009, 66:336-342.
56. Fleisch A.F., Agarwal N., Roberts M.D., Han J.C., Theim K.R., Vexler A., Troendle J., Yanovski S.Z., Yanovski J.A. Influence of serum leptin on weight and body fat growth in children at high risk for adult obesity. J. Clin. Endocrinol. Metab. 2007, 92:948-954.
57. Foschini D., Santos R.V., Prado W.L., de Piano A., Lofrano M.C., Martins A.C., Carnier J., Caranti D.A., Sanches Pde L., Tock L., Mello M.T., Tufik S., Damaso A.R. Platelet and leptin in obese adolescents. J. Pediatr. (Rio J.) 2008, 84:516-521.
58. Frei K., Malipiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 1989, 19:689-694.
59. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
60. Fruhbeck G. Intracellular signaling pathways activated by leptin. Biochem. J. 2006, 393:7-20.
61. Fry M., Smith P.M., Hoyda T.D., Duncan M., Ahima R.S., Sharkey K.A., Ferguson A.V. Area postrema neurons are modulated by the adipocyte hormone adiponectin. J. Neurosci. 2006, 26:9695-9702.
62. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., Maratos-Flier E., Flier J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-822.
63. Gadient R.A., Otten U.H. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 1997, 52:379-390.
64. Garden G.A., Moller T. Microglia biology in health and disease. J. Neuroimmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol. 2006, 1:127-137.
65. Gardes J., Bouhnik J., Clauser E., Corvol P., Menard J. Role of angiotensinogen in blood pressure homeostasis. Hypertension 1982, 4:185-189.
66. Gibertini M., Newton C., Friedman H., Klein T.W. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav. Immunity 1995, 9:113-128.
67. Giordano R., Picu A., Marinazzo E., D'Angelo V., Berardelli R., Karamouzis I., Forno D., Zinna D., Maccario M., Ghigo E., Arvat E. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission. Clin. Endocrinol. 2011, 75:354-360.
68. Gonzalez-Villalobos, R.A., Shen, X.Z., Bernstein, E.A., Janjulia, T., Taylor, B., Giani, J.F., Blackwell, W.L., Shah, K.H., Shi, P.D., Fuchs, S., Bernstein, K.E., 2013. Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme. J. Mol. Med.
69. Goossens G.H., Jocken J.W., Blaak E.E., Schiffers P.M., Saris W.H., van Baak M.A. Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation. Hypertension 2007, 49:542-547.
70. Graeber M.B., Streit W.J. Microglia: biology and pathology. Acta Neuropathol. 2010, 119:89-105.
71. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 2006, 83:461S-465S.
72. Grill H.J., Schwartz M.W., Kaplan J.M., Foxhall J.S., Breininger J., Baskin D.G. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 2002, 143:239-246.
73. Grobe J.L., Grobe C.L., Beltz T.G., Westphal S.G., Morgan D.A., Xu D., de Lange W.J., Li H., Sakai K., Thedens D.R., Cassis L.A., Rahmouni K., Mark A.L., Johnson A.K., Sigmund C.D. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010, 12:431-442.
74. Guan X.M., Hess J.F., Yu H., Hey P.J., van der Ploeg L.H. Differential expression of mRNA for leptin receptor isoforms in the rat brain. Mol. Cell. Endocrinol. 1997, 133:1-7.
75. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab. 2004, 30:13-19.
76. Guo L., Li Q., Wang W., Yu P., Pan H., Li P., Sun Y., Zhang J. Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B. Endocr. Res. 2009, 34:142-154.
77. Gustafson D. Adiposity indices and dementia. Lancet Neurol. 2006, 5:713-720.
78. Gustafson D., Bäckman K., Joas E., Waern M., Östling S., Guo X., Skoog I. A 37-year longitudinal follow-up of body mass index and dementia in women. J. Alzheimers Dis. 2012, 28:162-171.
79. Gustafson D.R. A life course of adiposity and dementia. Eur. J. Pharmacol. 2008, 585:163-175.
80. Gustafson D.R. Adiposity hormones and dementia. J. Neurol. Sci. 2010, 299:30-34.
81. Gustafson, D.R., 2012. Positive correlation between leptin and body weight or BMI, In: Communication, P. (Ed.), Also, elderly women and men show the similar positive correlation between leptin and body weight or BMI ed.
82. Gustafson D.R., Bäckman K., Waern M., Östling S., Guo X.X., Zandi P., Mielke M.M., Bengtsson C., Skoog I. Adiposity indicators and dementia over 32 years in Sweden. Neurology 2009, 73:1559-1566.
83. Gustafson D.R., Karlsson C., Skoog I., Rosengren L., Lissner L., Blennow K. Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J. Intern. Med. 2007, 262:643-650.
84. Gustafson D.R., Rothenberg E., Blennow K., Steen B., Skoog I. An 18-year follow up of overweight and risk for Alzheimer's disease. Arch. Intern. Med. 2003, 163:1524-1528.
85. Gustafson D.R., Steen B., Skoog I. Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int. Psychogeriatr. 2004, 16:327-336.
86. Haltia L.T., Viljanen A., Parkkola R., Kemppainen N., Rinne J.O., Nuutila P., Kaasinen V. Brain white matter expansion in human obesity and the recovering effect of dieting. J. Clin. Endocrinol. Metab. 2007, 92:3278-3284.
87. Harrison N. Inflammation and mental illness. J. Neurol. Neurosurg. Psychiatry. 2013, 84:e1.
88. Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr. Opin. Pharmacol. 2007, 7:643-647.
89. Hassenstab J.J., Sweet L.H., Del Parigi A., McCaffery J.M., Haley A.P., Demos K.E., Cohen R.A., Wing R.R. Cortical thickness of the cognitive control network in obesity and successful weight loss maintenance: a preliminary MRI study. Psychiatry Res. 2012, 202:77-79.
90. Hayden K.M., Zandi P.P., Lyketsos C.G., Khachaturian A.S., Bastian L.A., Charoonruk G., Tschanz J.T., Norton M.C., Pieper C.F., Munger R.G., Breitner J.C., Welsh-Bohmer K.A., Cache County I. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis. Assoc. Disord. 2006, 20:93-100.
91. Hayes M.R., Skibicka K.P., Leichner T.M., Guarnieri D.J., DiLeone R.J., Bence K.K., Grill H.J. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metab. 2010, 11:77-83.
92. Hermann G.E., Rogers R.C., Bresnahan J.C., Beattie M.S. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 2001, 8:590-599.
93. Hileman S.M., Pierroz D.D., Masuzaki H., Bjorbaek C., El-Haschimi K., Banks W.A., Flier J.S. Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 2002, 143:775-783.
94. Holland W.L., Adams A.C., Brozinick J.T., Bui H.H., Miyauchi Y., Kusminski C.M., Bauer S.M., Wade M., Singhal E., Cheng C.C., Volk K., Kuo M.S., Gordillo R., Kharitonenkov A., Scherer P.E. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 2013, 17:790-797.
95. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., Thurmon J.J., Marinelli M., DiLeone R.J. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51:801-810.
96. Hsueh W.A., Goldstone R., Carlson E.J., Horton R. Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms. J. Clin. Endocrinol. Metab. 1985, 61:399-403.
97. Huang X.F., Koutcherov I., Lin S., Wang H.Q., Storlien L. Localization of leptin receptor mRNA expression in mouse brain. Neuroreport 1996, 7:2635-2638.
98. Iadecola C., Davisson R.L. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008, 7:476-484.
99. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987, 325:253-257.
100. Jensen L.L., Harding J.W., Wright J.W. Role of paraventricular nucleus in control of blood pressure and drinking in rats. Am. J. Physiol. 1992, 262:F1068-F1075.
101. Jeon B.T., Shin H.J., Kim J.B., Kim Y.K., Lee D.H., Kim K.H., Kim H.J., Kang S.S., Cho G.J., Choi W.S., Roh G.S. Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity. Brain Res. Rev. 2009, 61:81-88.
102. Jeon H., Kim J.H., Kim J.H., Lee W.H., Lee M.S., Suk K. Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity. J. Neuroinflamm. 2012, 9:149.
103. Jequier E. Leptin signaling, adiposity, and energy balance. Ann. N. Y. Acad. Sci. 2002, 967:379-388.
104. Kakinuma Y., Hama H., Sugiyama F., Yagami K., Goto K., Murakami K., Fukamizu A. Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat. Med. 1998, 4:1078-1080.
105. Kastin A.J., Pan W., Maness L.M., Banks W.A. Peptides crossing the blood-brain barrier: some unusual observations. Brain Res. 1999, 848:96-100.
106. Kastin A.J., Pan W., Maness L.M., Koletsky R.J., Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 1999, 20:1449-1453.
107. Kim H.S., Krege J.H., Kluckman K.D., Hagaman J.R., Hodgin J.B., Best C.F., Jennette J.C., Coffman T.M., Maeda N., Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA 1995, 92:2735-2739.
108. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kareholt I., Winblad B., Helkala E.L., Tuomilehto J., Soininen H., Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62:1556-1560.
109. Kos K., Harte A.L., da Silva N.F., Tonchev A., Chaldakov G., James S., Snead D.R., Hoggart B., O'Hare J.P., McTernan P.G., Kumar S. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J. Clin. Endocrinol. Metab. 2007, 92:1129-1136.
110. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., Kozono H., Takamoto I., Okamoto S., Shiuchi T., Suzuki R., Satoh H., Tsuchida A., Moroi M., Sugi K., Noda T., Ebinuma H., Ueta Y., Kondo T., Araki E., Ezaki O., Nagai R., Tobe K., Terauchi Y., Ueki K., Minokoshi Y., Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 2007, 6:55-68.
111. Kusminski C.M., McTernan P.G., Schraw T., Kos K., O'Hare J.P., Ahima R., Kumar S., Scherer P.E. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 2007, 50:634-642.
112. Laywell E.D., Dorries U., Bartsch U., Faissner A., Schachner M., Steindler D.A. Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc. Natl. Acad. Sci. USA 1992, 89:2634-2638.
113. Lehr S., Hartwig S., Lamers D., Famulla S., Muller S., Hanisch F.G., Cuvelier C., Ruige J., Eckardt K., Ouwens D.M., Sell H., Eckel J. Identification and validation of novel adipokines released from primary human adipocytes. Mol. Cell. Proteomics 2012, 11. (M111 010504).
114. Leivo-Korpela S., Lehtimaki L., Vuolteenaho K., Nieminen R., Kankaanranta H., Saarelainen S., Moilanen E. Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma. J. Inflamm. 2011, 8:12.
115. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 1989, 86:6348-6352.
116. Loskutoff D.J., Sawdey M., Mimuro J. Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 1989, 9:87-115.
117. Lu X.Y., Kim C.S., Frazer A., Zhang W. Leptin: a potential novel antidepressant. Proc. Natl. Acad. Sci. USA 2006, 103:1593-1598.
118. Ludwin S.K. Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. Lab. Invest. 1985, 52:20-30.
119. MacDougald O.A., Burant C.F. The rapidly expanding family of adipokines. Cell Metab. 2007, 6:159-161.
120. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8:731-737.
121. Makni E., Moalla W., Lac G., Aouichaoui C., Cannon D., Elloumi M., Tabka Z. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Ann. Endocrinol. 2012, 73:26-33.
122. Mallat M., Marin-Teva J.L., Cheret C. Phagocytosis in the developing CNS: more than clearing the corpses. Curr. Opin. Neurobiol. 2005, 15:101-107.
123. Mantovani R.M., Rios D.R., Moura L.C., Oliveira J.M., Carvalho F.F., Cunha S.B., Viana Mde F., Lamounier J.A., Castro J.C., Dusse L.M., Simoes e Silva A.C. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity. J. Pediatr. Endocrinol. Metab. 2011, 24:361-367.
124. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U.L. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 2004, 279:32869-32881.
125. Maresh G.A., Maness L.M., Zadina J.E., Kastin A.J. In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier. Life Sci. 2001, 69:67-73.
126. Marsland A.L., Gianaros P.J., Abramowitch S.M., Manuck S.B., Hariri A.R. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 2008, 64:484-490.
127. Masos T., Miskin R. mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Brain Res. Mol. Brain Res. 1997, 47:157-169.
128. Massiera F., Bloch-Faure M., Ceiler D., Murakami K., Fukamizu A., Gasc J.M., Quignard-Boulange A., Negrel R., Ailhaud G., Seydoux J., Meneton P., Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001, 15:2727-2729.
129. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., Kumada M., Okamoto Y., Nagaretani H., Nishizawa H., Kishida K., Komuro R., Ouchi N., Kihara S., Nagai R., Funahashi T., Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 2002, 277:37487-37491.
130. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., Oldfield B.J., Mendelsohn F.A., Chai S.Y. The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 2003, 35:901-918.
131. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., Tsukumo D.M., Anhe G., Amaral M.E., Takahashi H.K., Curi R., Oliveira H.C., Carvalheira J.B., Bordin S., Saad M.J., Velloso L.A. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 2009, 29:359-370.
132. Milsted A., Barna B.P., Ransohoff R.M., Brosnihan K.B., Ferrario C.M. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc. Natl. Acad. Sci. USA 1990, 87:5720-5723.
133. Miskin R., Masos T. Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity. J. Gerontol. A Biol. Sci. Med. Sci. 1997, 52:B118-B124.
134. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
135. Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol. 2012, 7:42-59.
136. Morash B., Li A., Murphy P.R., Wilkinson M., Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology 1999, 140:5995-5998.
137. Morganti-Kossman M.C., Lenzlinger P.M., Hans V., Stahel P., Csuka E., Ammann E., Stocker R., Trentz O., Kossmann T. Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry 1997, 2:133-136.
138. Morrison C.D. Leptin signaling in brain: A link between nutrition and cognition?. Biochim. Biophys. Acta 2009, 1792:401-408.
139. Mousa S.A. Elevation of plasma von Willebrand factor and tumor necrosis factor-a in obese subjects and their reduction by the low molecular weight heparin tinzaparin. Int. Angiol. 2005, 24:278-281.
140. Mueller K., Anwander A., Moller H.E., Horstmann A., Lepsien J., Busse F., Mohammadi S., Schroeter M.L., Stumvoll M., Villringer A., Pleger B. Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One 2011, 6:e18544.
141. Munzberg H., Myers M.G. Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 2005, 8:566-570.
142. Myers M.G. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog. Horm. Res. 2004, 59:287-304.
143. Nishimura M., Izumiya Y., Higuchi A., Shibata R., Qiu J., Kudo C., Shin H.K., Moskowitz M.A., Ouchi N. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008, 117:216-223.
144. Novak V., Chowdhary A., Farrar B., Nagaraja H., Braun J., Kanard R., Novak P., Slivka A. Altered cerebral vasoregulation in hypertension and stroke. Neurology 2003, 60:1657-1663.
145. Nummenmaa L., Hirvonen J., Hannukainen J.C., Immonen H., Lindroos M.M., Salminen P., Nuutila P. Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. PLoS One 2012, 7:e31089.
146. Ogden, C.L., Carroll, M.D., 2010. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-1962 Through 2007-2008. Health E-Stats. June.
147. Ohkubo H., Kawakami H., Kakehi Y., Takumi T., Arai H., Yokota Y., Iwai M., Tanabe Y., Masu M., Hata J., et al. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc. Natl. Acad. Sci. USA 1990, 87:5153-5157.
148. Olde Dubbelink K.T., Felius A., Verbunt J.P., van Dijk B.W., Berendse H.W., Stam C.J., Delemarre-van de Waal H.A. Increased resting-state functional connectivity in obese adolescents; a magnetoencephalographic pilot study. PLoS One 2008, 3:e2827.
149. Oomura Y., Hori N., Shiraishi T., Fukunaga K., Takeda H., Tsuji M., Matsumiya T., Ishibashi M., Aou S., Li X.L., Kohno D., Uramura K., Sougawa H., Yada T., Wayner M.J., Sasaki K. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006, 27:2738-2749.
150. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
151. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14:561-566.
152. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., Okamoto Y., Ohashi K., Nagaretani H., Kishida K., Nishizawa H., Maeda N., Kobayashi H., Hiraoka H., Matsuzawa Y. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671-674.
153. Pan W., Kastin A.J. Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci. 2001, 68:2705-2714.
154. Pan W., Kastin A.J. Adipokines and the blood-brain barrier. Peptides 2007, 28:1317-1330.
155. Pannacciulli N., Del Parigi A., Chen K., Le D.S., Reiman E.M., Tataranni P.A. Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 2006, 31:1419-1425.
156. Pardridge W.M. Neuropeptides and the blood-brain barrier. Annu. Rev. Physiol. 1983, 45:73-82.
157. Paz-Filho G., Wong M.L., Licinio J. The procognitive effects of leptin in the brain and their clinical implications. Int. J. Clin. Pract. 2010, 64:1808-1812.
158. Peiser C., McGregor G.P., Lang R.E. Binding and internalization of leptin by porcine choroid plexus cells in culture. Neurosci. Lett. 2000, 283:209-212.
159. Pickering M., Cumiskey D., O'Connor J.J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol. 2005, 90:663-670.
160. Poluektova L., Meyer V., Walters L., Paez X., Gendelman H.E. Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis. Glia 2005, 52:344-353.
161. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., Scherer P.E., Ahima R.S. Adiponectin acts in the brain to decrease body weight. Nat. Med. 2004, 10:524-529.
162. Qiu G., Wan R., Hu J., Mattson M.P., Spangler E., Liu S., Yau S.Y., Lee T.M., Gleichmann M., Ingram D.K., So K.F., Zou S. Adiponectin protects rat hippocampal neurons against excitotoxicity. Age (Dordr) 2011, 33:155-165.
163. Raji C.A., Ho A.J., Parikshak N.N., Becker J.T., Lopez O.L., Kuller L.H., Hua X., Leow A.D., Toga A.W., Thompson P.M. Brain structure and obesity. Hum. Brain Mapp. 2010, 31:353-364.
164. Reid I.A. The brain renin-angiotensin system: a critical analysis. Fed. Proc. 1979, 38:2255-2259.
165. Rocha V.Z., Folco E.J. Inflammatory concepts of obesity. Int. J. Inflamm. 2011, 2011:529061.
166. Romanatto T., Cesquini M., Amaral M.E., Roman E.A., Moraes J.C., Torsoni M.A., Cruz-Neto A.P., Velloso L.A. TNF-alpha acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient-effects on leptin and insulin signaling pathways. Peptides 2007, 28:1050-1058.
167. Ropelle, E.R., Flores, M.B., Cintra, D.E., Rocha, G.Z., Pauli, J.R., Morari, J., de Souza, C.T., Moraes, J.C., Prada, P.O., Guadagnini, D., Marin, R.M., Oliveira, A.G., Augusto, T.M., Carvalho, H.F., Velloso, L.A., Saad, M.J., Carvalheira, J.B., 2010. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol. 8.
168. Salbe A.D., Weyer C., Lindsay R.S., Ravussin E., Tataranni P.A. Assessing risk factors for obesity between childhood and adolescence: I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin. Pediatrics 2002, 110:299-306.
169. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1345-R1356.
170. Schipper H.S., Nuboer R., Prop S., van den Ham H.J., de Boer F.K., Kesmir C., Mombers I.M., van Bekkum K.A., Woudstra J., Kieft J.H., Hoefer I.E., de Jager W., Prakken B., van Summeren M., Kalkhoven E. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14(++) monocytes. Diabetologia 2012.
171. Schulz C., Paulus K., Lehnert H. Adipocyte-brain: crosstalk. Results Probl. Cell Differ. 2010, 52:189-201.
172. Selmaj K., Raine C.S. Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Ann. NY Acad. Sci. 1988, 540:568-570.
173. Severs W.B., Changaris D.G., Keil L.C., Summy-Long J.Y., Klase P.A., Kapsha J.M. Pharmacology of angiotensin-induced drinking behavior. Fed. Proc. 1978, 37:2699-2703.
174. Severs W.B., Daniels-Severs A.E. Effects of angiotensin on the central nervous system. Pharmacol. Rev. 1973, 25:415-449.
175. Shioda S., Funahashi H., Nakajo S., Yada T., Maruta O., Nakai Y. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci. Lett. 1998, 243:41-44.
176. Simpson J.B. The circumventricular organs and the central actions of angiotensin. Neuroendocrinology 1981, 32:248-256.
177. Singh A., Foster G.D., Gunawardana J., McCoy T.A., Nguyen T., Vander Veur S., Komaroff E., Rao A.K. Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state. Br. J. Haematol. 2012, 158:523-527.
178. Sitcheran R., Gupta P., Fisher P.B., Baldwin A.S. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. EMBO J. 2005, 24:510-520.
179. Skurk T., Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int. J. Obes. Relat. Metab. Disord. 2004, 28:1357-1364.
180. Soeda S., Koyanagi S., Kuramoto Y., Kimura M., Oda M., Kozako T., Hayashida S., Shimeno H. Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb. Haemost. 2008, 100:1014-1020.
181. Soeda S., Oda M., Ochiai T., Shimeno H. Deficient release of plasminogen activator inhibitor-1 from astrocytes triggers apoptosis in neuronal cells. Brain Res. Mol. Brain Res. 2001, 91:96-103.
182. Spranger J., Verma S., Gohring I., Bobbert T., Seifert J., Sindler A.L., Pfeiffer A., Hileman S.M., Tschop M., Banks W.A. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006, 55:141-147.
183. Stanek K.M., Grieve S.M., Brickman A.M., Korgaonkar M.S., Paul R.H., Cohen R.A., Gunstad J.J. Obesity is associated with reduced white matter integrity in otherwise healthy adults. Obesity (Silver Spring) 2011, 19:500-504.
184. Stelzer I., Zelzer S., Raggam R.B., Pruller F., Truschnig-Wilders M., Meinitzer A., Schnedl W.J., Horejsi R., Moller R., Weghuber D., Reeves G., Postolache T.T., Mangge H. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl. Res. 2012, 159:118-124.
185. Stoeckel L.E., Kim J., Weller R.E., Cox J.E., Cook E.W., Horwitz B. Effective connectivity of a reward network in obese women. Brain Res. Bull. 2009, 79:388-395.
186. Stornetta R.L., Hawelu-Johnson C.L., Guyenet P.G., Lynch K.R. Astrocytes synthesize angiotensinogen in brain. Science 1988, 242:1444-1446.
187. Tam C.S., Garnett S.P., Cowell C.T., Heilbronn L.K., Lee J.W., Wong M., Baur L.A. IL-6, IL-8 and IL-10 levels in healthy weight and overweight children. Horm. Res. Paediatr. 2010, 73:128-134.
188. Tancredi V., D'Arcangelo G., Grassi F., Tarroni P., Palmieri G., Santoni A., Eusebi F. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci. Lett. 1992, 146:176-178.
189. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Wool E.A., Monroe C.A., Tepper R.I. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
190. Thaler J.P., Yi C.X., Schur E.A., Guyenet S.J., Hwang B.H., Dietrich M.O., Zhao X., Sarruf D.A., Izgur V., Maravilla K.R., Nguyen H.T., Fischer J.D., Matsen M.E., Wisse B.E., Morton G.J., Horvath T.L., Baskin D.G., Tschop M.H., Schwartz M.W. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012, 122:153-162.
191. Thornton S.N., Nicolaidis S. Blood pressure effects of iontophoretically applied bioactive hormones in the anterior forebrain of the rat. Am. J. Physiol. 1993, 265:R826-R833.
192. Ukkola O., Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. J. Mol. Med. 2002, 80:696-702.
193. Valerio A., Ghisi V., Dossena M., Tonello C., Giordano A., Frontini A., Ferrario M., Pizzi M., Spano P., Carruba M.O., Nisoli E. Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. J. Biol. Chem. 2006, 281:12950-12958.
194. Van Harmelen V., Ariapart P., Hoffstedt J., Lundkvist I., Bringman S., Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes. Res. 2000, 8:337-341.
195. van Harmelen V., Elizalde M., Ariapart P., Bergstedt-Lindqvist S., Reynisdottir S., Hoffstedt J., Lundkvist I., Bringman S., Arner P. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int. J. Obes. Relat. Metab. Disord. 2000, 24:673-678.
196. van Rossum C.T., Hoebee B., van Baak M.A., Mars M., Saris W.H., Seidell J.C. Genetic variation in the leptin receptor gene, leptin, and weight gain in young Dutch adults. Obes. Res. 2003, 11:377-386.
197. Villarreal-Molina M.T., Antuna-Puente B. Adiponectin: Anti-inflammatory and cardioprotective effects. Biochimie 2012, 94:2143-2149.
198. Visser M. Higher levels of inflammation in obese children. Nutrition 2001, 17:480-481.
199. Walker W.G., Whelton P.K., Saito H., Russell R.P., Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979, 1:287-291.
200. Watt G.C., Harrap S.B., Foy C.J., Holton D.W., Edwards H.V., Davidson H.R., Connor J.M., Lever A.F., Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J. Hypertens. 1992, 10:473-482.
201. Wei H., Chadman K.K., McCloskey D.P., Sheikh A.M., Malik M., Brown W.T., Li X. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. Biochim. Biophys. Acta 2012, 1822:831-842.
202. Wei H., Zou H., Sheikh A.M., Malik M., Dobkin C., Brown W.T., Li X. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J. Neuroinflamm. 2011, 8:52.
203. Weiland F., Verspohl E.J. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes. Horm. Metab. Res. 2008, 40:760-766.
204. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.
205. White D.W., Kuropatwinski K.K., Devos R., Baumann H., Tartaglia L.A. Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J. Biol. Chem. 1997, 272:4065-4071.
206. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 2007, 4:103-109.
207. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71:1057-1064.
208. WHO, 2012. Obesity and Overweight.
209. Widya R.L., de Roos A., Trompet S., de Craen A.J., Westendorp R.G., Smit J.W., van Buchem M.A., van der Grond J. Increased amygdalar and hippocampal volumes in elderly obese individuals with or at risk of cardiovascular disease. Am. J. Clin. Nutr. 2011, 93:1190-1195.
210. Wiesner G., Vaz M., Collier G., Seals D., Kaye D., Jennings G., Lambert G., Wilkinson D., Esler M. Leptin is released from the human brain: influence of adiposity and gender. J. Clin. Endocrinol. Metab. 1999, 84:2270-2274.
211. Wilkinson M., Brown R., Imran S.A., Ur E. Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007, 86:191-209.
212. Wilsey J., Zolotukhin S., Prima V., Scarpace P.J. Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R1011-R1020.
213. Woo M.S., Park J.S., Choi I.Y., Kim W.K., Kim H.S. Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J. Neurochem. 2008, 106:770-780.
214. Xu W.L., Atti A.R., Gatz M., Pedersen N.L., Johansson B., Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 2011, 76:1568-1574.
215. Yaffe K., Haan M., Blackwell T., Cherkasova E., Whitmer R.A., West N. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J. Am. Geriatr. Soc. 2007, 55:758-762.
216. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B. The metabolic syndrome, inflammation, and risk of cognitive decline. J. Am. Med. Assoc. 2004, 292:2237-2242.
217. Yamashita T., Murakami T., Iida M., Kuwajima M., Shima K. Leptin receptor of Zucker fatty rat performs reduced signal transduction. Diabetes 1997, 46:1077-1080.
218. Yanai K., Saito T., Kakinuma Y., Kon Y., Hirota K., Taniguchi-Yanai K., Nishijo N., Shigematsu Y., Horiguchi H., Kasuya Y., Sugiyama F., Yagami K., Murakami K., Fukamizu A. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J. Biol. Chem. 2000, 275:5-8.
219. Yiannikouris F., Gupte M., Putnam K., Thatcher S., Charnigo R., Rateri D.L., Daugherty A., Cassis L.A. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012, 60:1524-1530.
220. Yiannikouris F., Karounos M., Charnigo R., English V.L., Rateri D.L., Daugherty A., Cassis L.A. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R244-R251.
221. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., Kihara S., Funahashi T., Tenner A.J., Tomiyama Y., Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
222. Youssef A.M., Hamidian Jahromi A., Vijay C.G., Granger D.N., Alexander J.S. Intra-abdominal hypertension causes reversible blood-brain barrier disruption. J. Trauma Acute Care Surg. 2012, 72:183-188.
223. Yvan-Charvet L., Quignard-Boulange A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int. 2011, 79:162-168.
224. Zeki Al Hazzouri A., Stone K.L., Haan M.N., Yaffe K. Leptin, mild cognitive impairment, and dementia among elderly women. J. Gerontol. A: Biol. Sci. Med. Sci 2013, 68:175-180.
225. Zhang F., Wang S., Signore A.P., Chen J. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 2007, 38:2329-2336.
226. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
227. Zlokovic B.V., Jovanovic S., Miao W., Samara S., Verma S., Farrell C.L. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology 2000, 141:1434-1441.